Valeo Pharma (TSX:VPH) Accounts Payable & Accrued Expense : C$15.79 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Accounts Payable & Accrued Expense?

Valeo Pharma's quarterly accounts payable & accrued expense declined from Jul. 2023 (C$14.37 Mil) to Oct. 2023 (C$11.42 Mil) but then increased from Oct. 2023 (C$11.42 Mil) to Jan. 2024 (C$15.79 Mil).

Valeo Pharma's annual accounts payable & accrued expense increased from Oct. 2021 (C$10.22 Mil) to Oct. 2022 (C$12.46 Mil) but then declined from Oct. 2022 (C$12.46 Mil) to Oct. 2023 (C$11.42 Mil).

Valeo Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Valeo Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Accounts Payable & Accrued Expense Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

4.38

4.11

10.22

12.46

11.42

Valeo Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															7.12	13.13	14.37	11.42	15.79

Valeo Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Valeo Pharma (TSX:VPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

VPHIF:USA

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Executives

Luc Mainville

Senior Officer

Valeo Pharma (TSX:VPH) Headlines

No Headlines